# Pardes Bio

**Canonical:** https://apis.io/providers/pardes-bio/  
**APIs profiled:** 0

Pardes Biosciences was a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. Founded in 2020 and based in Carlsbad, California, it used structure-based drug design and a tunable, reversible covalent chemistry platform. Its lead candidate, PBI-0451, was an oral direct-acting antiviral for SARS-CoV-2. The company was acquired in 2023 and no longer operates independently. It has no public API, developer program, or technical integration surface, and its former domain (pardesbio.com) is now a parked/registrar page.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Biopharmaceutical, Pharmaceuticals, Drug Discovery, Antivirals, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/pardes-bio/). Scores are computed from the provider's own public artifacts under a published rubric.